Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

INTERNEURON DEAL FOR ALZHEIMER'S DRUG

Aug. 20, 1991

FDA SEIZES COLLAGEN PRODUCTS

Aug. 19, 1991

AMGEN GETS $25M LIEN AGAINST GI

Aug. 19, 1991

INNOVET GRANTS RIGHTS TO BIO-POLYMER SYSTEM

Aug. 19, 1991

CALGENE TO FOCUS ON CORE CROPS

Aug. 19, 1991

APPOINTMENTS AND ADVANCEMENTS

Aug. 19, 1991

MIMETICS MAY HERALD A NEW CLASS OF DRUGS

Aug. 16, 1991

ANALYST RECOMMENDS TAKING PROFITS ON ICOS

Aug. 16, 1991

KODAK SEEKS INJUNCTION AGAINST CETUS

Aug. 16, 1991

COLUMBIA LABS RAISES $12M IN PRIVATE PLACEMENT

Aug. 16, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...